IL97726A - Pharmaceutical preparations containing compounds with bridged and unbridged heterocyclic groups connected via spiro-atop with oxazoline and thiazoline groups, and sharp compounds - Google Patents

Pharmaceutical preparations containing compounds with bridged and unbridged heterocyclic groups connected via spiro-atop with oxazoline and thiazoline groups, and sharp compounds

Info

Publication number
IL97726A
IL97726A IL9772691A IL9772691A IL97726A IL 97726 A IL97726 A IL 97726A IL 9772691 A IL9772691 A IL 9772691A IL 9772691 A IL9772691 A IL 9772691A IL 97726 A IL97726 A IL 97726A
Authority
IL
Israel
Prior art keywords
compounds
alkyl
oxazoline
pharmaceutical composition
composition according
Prior art date
Application number
IL9772691A
Other languages
English (en)
Hebrew (he)
Inventor
Abraham Fisher
Yoffi Segall
Ezra Shirin
Yishai Karton
Haim Meshulam
Original Assignee
Israel Inst Biolog Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/507,228 external-priority patent/US5053412A/en
Application filed by Israel Inst Biolog Res filed Critical Israel Inst Biolog Res
Publication of IL97726A publication Critical patent/IL97726A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9772691A 1990-04-10 1991-03-28 Pharmaceutical preparations containing compounds with bridged and unbridged heterocyclic groups connected via spiro-atop with oxazoline and thiazoline groups, and sharp compounds IL97726A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50770890A 1990-04-10 1990-04-10
US07/507,228 US5053412A (en) 1990-04-10 1990-04-10 Spiro nitrogen-bridged heterocyclic compounds
AU81241/91A AU636047B2 (en) 1990-04-10 1991-07-23 Spiro bridged and unbridged heterocyclic compounds

Publications (1)

Publication Number Publication Date
IL97726A true IL97726A (en) 1994-12-29

Family

ID=27156423

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9772691A IL97726A (en) 1990-04-10 1991-03-28 Pharmaceutical preparations containing compounds with bridged and unbridged heterocyclic groups connected via spiro-atop with oxazoline and thiazoline groups, and sharp compounds

Country Status (8)

Country Link
EP (1) EP0452101B1 (de)
JP (1) JP3266624B2 (de)
AT (1) ATE181920T1 (de)
AU (1) AU636047B2 (de)
CA (1) CA2039826C (de)
DE (1) DE69131409T2 (de)
ES (1) ES2137926T3 (de)
IL (1) IL97726A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
DE69516524T2 (de) * 1994-08-24 2001-01-18 Astrazeneca Ab, Soedertaelje Therapeutisch verwendbare spiro-azabicyclische verbindungen
US7863291B2 (en) * 2008-04-23 2011-01-04 Bristol-Myers Squibb Company Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8309577B2 (en) 2008-04-23 2012-11-13 Bristol-Myers Squibb Company Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
US9034891B2 (en) 2009-01-26 2015-05-19 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
KR101675174B1 (ko) * 2009-01-26 2016-11-10 이스라엘 인스티튜트 포 바이올로지컬 리서치 이환형 헤테로사이클릭 스피로 화합물
CN102686595A (zh) 2009-10-28 2012-09-19 百时美施贵宝公司 作为α-7 烟碱乙酰胆碱受体配体的氮杂二环化合物
US8278320B2 (en) 2009-10-28 2012-10-02 Bristol-Myers Squibb Company Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
EP2493892B1 (de) * 2009-10-29 2015-07-01 Bristol-Myers Squibb Company Chinuklidine-derivate als alpha-7 nikotin acetylcholin rezeptor liganden
CN101798311A (zh) * 2010-04-07 2010-08-11 天津炜杰凯华科技有限公司 顺式西维美林的制备方法
CN103025744A (zh) 2010-04-30 2013-04-03 百时美施贵宝公司 作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物
WO2013177024A1 (en) * 2012-05-24 2013-11-28 Bristol-Myers Squibb Company QUINUCLIDINE, 1-AZABICYCLO[2.2.1]HEPTANE, 1-AZABICYCLO [3.2.1]OCTANE, and 1-AZABICYCLO[3.2.2]NONANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
JP5714745B2 (ja) * 2014-04-28 2015-05-07 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ α７ニコチン性アセチルコリン受容体リガンドとしてのキヌクリジン化合物
US20230348493A1 (en) * 2020-05-12 2023-11-02 Beijing Greatway Pharmaceutical Technology Co., Ltd. Compound for adjusting activity of nmda receptor, and pharmaceutical composition and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629276A (en) * 1969-07-16 1971-12-21 Abbott Lab 2-amino-5-spiro-substituted-oxazo compounds
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
GB8816299D0 (en) * 1988-07-08 1988-08-10 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
EP0452101B1 (de) 1999-07-07
AU8124191A (en) 1993-01-28
DE69131409T2 (de) 2000-02-03
AU636047B2 (en) 1993-04-08
ES2137926T3 (es) 2000-01-01
CA2039826A1 (en) 1991-10-11
ATE181920T1 (de) 1999-07-15
EP0452101A3 (en) 1993-02-24
CA2039826C (en) 2002-01-15
DE69131409D1 (de) 1999-08-12
EP0452101A2 (de) 1991-10-16
JPH06293761A (ja) 1994-10-21
JP3266624B2 (ja) 2002-03-18

Similar Documents

Publication Publication Date Title
US5852029A (en) Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) Spiro compounds containing five-membered rings
DE60113865T2 (de) Piperazin derivate
AU775426B2 (en) New compounds
JP3042894B2 (ja) サブスタンスｐアンタゴニストとしての置換ベンゾラクタム化合物
US5073560A (en) Spiro-isoxazolidine derivatives as cholinergic agents
AU744259B2 (en) Analogs of cocaine
EP0452101B1 (de) Ueberbrückte und nicht-überbrückte heterocyclische Spiroverbindungen
PL172069B1 (pl) Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
DK175064B1 (da) Spiro-oxathiolan/quinuclidinforbindelser, præparat indeholdende disse og anvendelse af disse til fremstilling af et farmaceutisk præparat
US5407938A (en) Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
NO177711B (no) Analogifremgangsmåte for fremstilling av terapautisk aktive azabicyklo- og azacyklo- oksimer og -aminer
US5053412A (en) Spiro nitrogen-bridged heterocyclic compounds
EP1178047B1 (de) Diazacyclooctanverbindungen und ihre therapeutische Verwendung
MX2007000948A (es) (1s, 5s)-3-(5, 6-dicloro-3 -piridinil)-3, 6-diazabiciclo [3.2.0] heptano.
AU597412B2 (en) Substituted hexahydroarylquinolizines
HUT58318A (en) Process for producing pirimidinyl derivatives
US4831035A (en) Substituted hexahydroarylquinolizines
KR100222238B1 (ko) 스피로 교상 및 비교상 헤테로고리 화합물
NO304522B1 (no) AnologifremgangsmÕte for fremstilling av terapeutisk aktive heterocykliske forbindelser
US20050137225A1 (en) Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands
TW201312B (en) Spiro bridged and unbridged heterocyclic compounds
US4916223A (en) Substituted hexahydroarylquinolizines
CA2146000A1 (en) 3,3-disubstituted tri-and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders
Liu Synthesis and Biological Evaluation of Novel Epibatidine Analogues

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees